Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 4 3Phase 3 2Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1CNS 1

Conditions

Seizures 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 52Radiosurgery 38Radiotherapy 24Blood Specimen Collection 21Magnetic Resonance Imaging 17Bevacizumab 16Temozolomide 13Radiation 12Proton Therapy 10Specimen Handling 9Radiotherapy, Intensity-Modulated 9Mental Status and Dementia Tests 9Carboplatin 9Surgical Procedures, Operative 8Exercise 8Dexmedetomidine 8Vincristine 7Surveys and Questionnaires 7Spinal Puncture 7Etoposide 7Drug Therapy 7Biopsy 7Saline Solution 6Diffusion Tensor Imaging 6Dexamethasone 6Cyclophosphamide 6Therapeutics 5Standard of Care 5Restraint, Physical 5Propofol 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Levetiracetam × CNS × Clear all
NCT00415376 2012-05-18

Levetiracetam in Treating Patients With Seizures Caused by Brain Metastases

Northwestern University

Phase NA Withdrawn
CNS

Brain Neoplasms, Seizures, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡